Esperion Therapeutics
ESPR
#6713
Rank
A$0.75 B
Marketcap
$3.85
Share price
2.02%
Change (1 day)
102.83%
Change (1 year)

Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Volume in USD (price x number of shares), data since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$15.07 M123.49%
2023A$6.74 M-17.88%
2022A$8.21 M-92.54%
2021A$0.11 B-22.56%
2020A$0.14 B231.53%
2019A$42.87 M-67.65%
2018A$0.13 B186.16%
2017A$46.31 M130.83%
2016A$20.06 M-80.53%
2015A$0.10 B663.91%
2014A$13.49 M840.1%
2013A$1.43 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$0.76 MA$6.92 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.17 MA$17.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.21 MA$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.63 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.11 MA$6.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.68 MA$21.62 M๐Ÿ‡บ๐Ÿ‡ธ USA